胆囊切除术后>1年因良性指征首次ERCP的增加与更差结局相关
基于商业保险理赔数据库583712例成人胆囊切除术数据,4274例接受迟发ERCP(术后>1年因非恶性指征首次ERCP)。尽管无创胆道影像使用增加,迟发ERCP率2005至2021年增加8倍,且与ERCP后胰腺炎、住院及新发慢性阿片类药物使用相关。
要点
- 迟发ERCP率从2005年0.5/1000人年升至2021年4.2/1000人年,增加8倍(P<.001)。
- 迟发ERCP后仅44%患者取出胆结石,ERCP后胰腺炎发生率7.1%,住院13.1%,新发慢性阿片类使用9.7%。
- 与迟发ERCP相关的因素包括肠-脑互动障碍(OR 6.48)、代谢功能障碍性脂肪性肝病(OR 3.27)及抗焦虑药、解痉药、慢性阿片类使用。
核心结论
- 胆囊切除术后迟发ERCP率显著增加,尤其在伴有肠-脑互动障碍及胆总管结石类似症合并症的患者中;迟发ERCP与不成比例的高不良事件率相关,包括开始慢性阿片类药物使用。
研究设计与样本
- 基于商业保险理赔数据库(Optum Clinformatics)识别583712例接受胆囊切除术的成人,其中4274例接受迟发ERCP(胆囊切除术后>1年因非恶性指征首次ERCP)。
- 采用多变量逻辑回归分析与接受迟发ERCP相关的患者特征。
主要发现
- 无创胆道影像使用率从2004年35.9%升至2021年65.6%(P<.001),但迟发ERCP率从2005年0.5/1000人年升至2021年4.2/1000人年,增加8倍(P<.001)。
- 迟发ERCP患者中仅44%取出胆结石,ERCP后胰腺炎发生率7.1%,住院率13.1%,新发慢性阿片类使用率9.7%。
- 与迟发ERCP相关的因素包括肠-脑互动障碍(OR 6.48;95%CI 5.88-6.91)、代谢功能障碍性脂肪性肝病(OR 3.27;95%CI 2.79-3.55)、抗焦虑药使用(OR 3.45;95%CI 3.19-3.58)、解痉药使用(OR 1.60;95%CI 1.53-1.72)及慢性阿片类使用(OR 6.24;95%CI 5.79-6.52)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Greater availability of less invasive biliary imaging to rule out choledocholithiasis should reduce the need for diagnostic endoscopic retrograde cholangiopancreatography (ERCP) in patients who have a remote history of cholecystectomy. The primary aims were to determine the incidence, characteristics, and outcomes of individuals who undergo first-time ERCP >1 year after cholecystectomy (late-ERCP). METHODS: Data from a commercial insurance claim database (Optum Clinformatics) identified 583,712 adults who underwent cholecystectomy, 4274 of whom underwent late-ERCP, defined as first-time ERCP for nonmalignant indications >1 year after cholecystectomy. Outcomes were exposure and temporal trends in late-ERCP, biliary imaging utilization, and post-ERCP outcomes. Multivariable logistic regression was used to examine patient characteristics associated with undergoing late-ERCP. RESULTS: Despite a temporal increase in the use of noninvasive biliary imaging (35.9% in 2004 to 65.6% in 2021; P < .001), the rate of late-ERCP increased 8-fold (0.5-4.2/1000 person-years from 2005 to 2021; P < .001). Although only 44% of patients who underwent late-ERCP had gallstone removal, there were high rates of post-ERCP pancreatitis (7.1%), hospitalization (13.1%), and new chronic opioid use (9.7%). Factors associated with late-ERCP included concomitant disorder of gut-brain interaction (odds ratio [OR], 6.48; 95% confidence interval [CI], 5.88-6.91) and metabolic dysfunction steatotic liver disease (OR, 3.27; 95% CI, 2.79-3.55) along with use of anxiolytic (OR, 3.45; 95% CI, 3.19-3.58), antispasmodic (OR, 1.60; 95% CI, 1.53-1.72), and chronic opioids (OR, 6.24; 95% CI, 5.79-6.52). CONCLUSIONS: The rate of late-ERCP postcholecystectomy is increasing significantly, particularly in patients with comorbidities associated with disorder of gut-brain interaction and mimickers of choledocholithiasis. Late-ERCPs are associated with disproportionately higher rates of adverse events, including initiation of chronic opioid use.
引用
- Thiruvengadam NR, Saumoy M, Schaubel DE, et al. Rise in First-Time ERCP for Benign Indications >1 Year After Cholecystectomy Is Associated With Worse Outcomes. Clin Gastroenterol Hepatol. 2024. PMID: 38599308. doi:10.1016/j.cgh.2024.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。